Artificial intelligence for coordinating vaccine design, antiviral discovery, and real-world monitoring in the era of emerging and endemic viral threats
Mayowa Shekoni
Vaccine development has traditionally been a lengthy and resource-intensive process, often struggling to keep pace with rapidly emerging infectious threats. Recent advances in artificial intelligence (AI) offer new opportunities to transform this landscape by enabling faster, more precise, and data-driven approaches to vaccine design. This review examines how AI is being applied across key stages of vaccine development, including antigen discovery, epitope prediction, structural optimisation, im